ArticleTomography (Ann Arbor, Mich.)2026
Bidirectional Perceptual Multimodal Interaction Network Based on Contrastive Learning for Breast Cancer pCR Prediction.
Article in Tomography (Ann Arbor, Mich.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
BACKGROUND/
objectivesEarly and accurate prediction of pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) is vital for personalized breast cancer treatment. However, existing deep learning methods are hampered by tumor heterogeneity and semantic misalignment between high-dimensional dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and low-dimensional clinical data, which limits pCR prediction performance and generalization. This study addresses these challenges via a novel multimodal network.
methodsWe propose a Bidirectional Perceptual Multimodal Interaction Network (BPMINet) based on contrastive learning. BPMINet integrates pre-NAC DCE-MRI and clinical information through three core components: (1) we propose a bidirectional cross-modal attention (BiCMA) fusion mechanism to resolve semantic misalignment and facilitate effective multimodal feature fusion; (2) we design a multimodal contrast-aware feature enhancement (MCFE) module as a key component tightly integrated into the pCR-oriented contrastive learning framework, which serves to boost discriminative power for pCR prediction and improve generalization performance on hard-to-classify samples; (3) we adopt a dual-loss strategy to enable the collaborative optimization of discriminative feature representation and pCR prediction performance.
resultsOn two publicly available multicenter datasets, BPMINet outperformed all comparative methods across seven evaluation metrics: specifically, it surpassed the top-performing baseline by 5.17% in AUC and 5.24% in accuracy on the MAMA-MIA dataset. More notably, it achieved substantially larger gains of 11.72% in AUC and 7.38% in accuracy on the ISPY1 dataset.
conclusionsBPMINet achieves optimal pCR prediction performance, confirming its superiority and strong generalization ability for multimodal breast cancer pCR prediction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.